US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Bellevue Gold Limited (BGL) 銘柄情報

Bellevue Gold Limited (BGL)

1.385

-0.08

(-5.46%)

終了 6月6日 3:00PM

Bellevue Gold Limited (BGL) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

1.385

( -5.46% )

買値

1.385

売値

1.39

出来高

5,985,464

1.385 日の範囲 1.47

0.60 52 週間の範囲 2.00

時価総額

前日終値

1.465

始値

1.47

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 7,878,234

発行済株式数

1,488,450,227

配当利回り

PER

-38.63

1 株当たり利益 (EPS)

-0.04

歳入

441.36M

純利益

-55.32M

Bellevue Gold Limited, together with its subsidiaries, engages in the exploration, development, mining, and processing of gold properties in Australia. The company primarily holds interest in the Bellevue gold project located to north-west of Leinster in the Goldfields region of Western Australia. T... Bellevue Gold Limited, together with its subsidiaries, engages in the exploration, development, mining, and processing of gold properties in Australia. The company primarily holds interest in the Bellevue gold project located to north-west of Leinster in the Goldfields region of Western Australia. The company was formerly known as Draig Resources Limited and changed its name to Bellevue Gold Limited in July 2018. Bellevue Gold Limited was incorporated in 2004 and is based in West Perth, Australia. 詳細を表示

セクター

Materials

業界

Mining

ウェブサイト

bellevuegold.com.au

本社

West Perth, Australia

設立

2026

Bellevue Gold Limited is listed in the Materials sector of the オーストラリア証券取引所 with ticker BGL. The last closing price for Bellevue Gold was AUD1.47. Over the last year, Bellevue Gold shares have traded in a share price range of AUD 0.60 to AUD 2.00.

Bellevue Gold currently has 1,488,450,227 shares in issue. The market capitalisation of Bellevue Gold is AUD2.06 billion. Bellevue Gold has a price to earnings ratio (PE ratio) of -38.63.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.16	-10.355987055	1.545	1.57	1.385	4804506	1.50787636	DE
4	-0.235	-14.5061728395	1.62	1.73	1.385	5345542	1.55508738	DE
12	-0.28	-16.8168168168	1.665	2	0.75	7499306	1.54731923	DE
26	-0.035	-2.46478873239	1.42	2	0.75	8603292	1.64584987	DE
52	0.435	45.7894736842	0.95	2	0.6	11793077	1.23851918	DE
156	0.05	3.74531835206	1.335	2.1	0.6	8674656	1.30586709	DE
260	0.56	67.8787878788	0.825	2.1	0.6	6460351	1.24556674	DE

BGL - Frequently Asked Questions (FAQ)

What is the current Bellevue Gold Limited share price?

The current share price of Bellevue Gold Limited is AUD 1.385

How many Bellevue Gold Limited shares are in issue?

Bellevue Gold Limited has 1,488,450,227 shares in issue

What is the market cap of Bellevue Gold Limited?

The market capitalisation of Bellevue Gold Limited is AUD 2.06B

What is the 1 year trading range for Bellevue Gold Limited share price?

Bellevue Gold Limited has traded in the range of AUD 0.60 to AUD 2.00 during the past year

What is the PE ratio of Bellevue Gold Limited?

The price to earnings ratio of Bellevue Gold Limited is -38.63

What is the cash to sales ratio of Bellevue Gold Limited?

The cash to sales ratio of Bellevue Gold Limited is 5.13

What is the registered address of Bellevue Gold Limited?

The registered address for Bellevue Gold Limited is 24 Outram Street, West Perth, Western Australia, 6005

What is the Bellevue Gold Limited website address?

The website address for Bellevue Gold Limited is bellevuegold.com.au

Which industry sector does Bellevue Gold Limited operate in?

Bellevue Gold Limited operates in the Mining sector

US Market News

US Market News 2分前

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA BerobenatideJune 6, 2026 9:00 AM
Business Wire Results from multiple Phase 2b dose finding studies for berobenatide (PF’3944) highlight a potential first-in

Investor082

Investor082 2分前

They are all a bunch of BS artists! They have trapped many naive retail families over the years by providing false hope and expectations.

Investor082

Investor082 4分前

See you in 2028 then! LP is likely to abandon Eden before that at some point than secure a commercial certification in 2028.

Keep a ton of dry powder. Looking forward to you bragging about averaging down in the coming weeks and months, LOL! ;)

Investor082

Investor082 7分前

In that case, forget about 2026 and 2027. Likely 2028 as well. C lab and Eden won’t certified for commercial production until 2028 at the earliest. Its more likely they will abandon Eden than secure commercial certification even in 2028. Have fun with the endless dilution in pennies! ;)

WhiteOwl

WhiteOwl 8分前

Am I missing something or does that Video say everything is experimental or just theory? I was under the impression they had perfected a workable unit? Just saying.

THE OLD OWL 🦉🦉🦉

hardlesson

hardlesson 11分前

You're one of the hardest working guys on ihub. Banging out the charts on a Saturday morning. Thanks always, and have a good weekend. :)

Investor082

Investor082 11分前

LP will be back there again in a couple years still pleading for a change (pathway act) so she can submit regulatory application to FDA in 2030, LOL!

Meanwhile outstanding shares ballooned to 5B+, LOL! ;)

WhiteOwl

WhiteOwl 12分前

Am I missing something or does that Video say everything is experimental or just theory? I was under the impression they had perfected a workable unit? Just saying.

THE OLD OWL 🦉🦉🦉

glenn1919

glenn1919 15分前

BCDA......BMGL.......BGMS......ACCL......CMND.........CGTL...........https://stockcharts.com/sc3/ui/?s=CMND&p=w&yr=1&mn=3&dy=0&id=p96837884856

Investor082

Investor082 16分前

No excuses when LP disappoints on this, OK?

I will check in on this message whenever there is a decision, LOL! ;)

WhenLambo

WhenLambo 16分前

FIFA is already on public record marketing them, what could be bigger than that? They’ll continue to put VuMe out there next week

train21

train21 17分前

DRIVEN IS BACK
so I guess we going to see 5 cents again ? well are we ?

Investor082

Investor082 19分前

Don't let LP and her toxic financiers screw you year after year, LOL! ;)

Instead invest in well known AI and tech stocks run by solid management crew.

glenn1919

glenn1919 20分前

STAK......SPHL.....SMTK......SAOR.....SNBR.......SCAG.....SPPL..................................https://stockcharts.com/sc3/ui/?s=SCAG&p=w&yr=1&mn=3&dy=0&id=p96837884856

jackinthegreen

jackinthegreen 20分前

Exactly - another round of press and hype can drive the price up a bit, but without substantial new contracts and revenue outside the consumer electronics space, it will only be a temporary bump. We’ve been here before - buying on the rumor is great, but what we need is actual profitability.

train21

train21 20分前

BOTH CEOs BLOCKED ME ON X
I MUST HAVE HIT THE NAIL ON THE HEAD
ANY CEO THAT BLOCKS QUESTIONS OF THEIR DECISIONS IS HIDING SOMETHING BIG AND BAD ???

rodman

rodman 21分前

There appears to be some life left in UEEC based upon the buying and pps increase this week.

cottonmather

cottonmather 21分前

Drey Dossier. The WH Ballroom ain't what it used to be. 17 minutes https://youtu.be/VbJ4ilDvGyc?si=DispyZYqLVQNJyms

USAFpatriot

USAFpatriot 21分前

Annual meeting 8k.

https://investorshub.advfn.com/stock-market/NASDAQ/novocure-NVCR/stock-news/98686681/form-8-k-current-report

train21

train21 22分前

$GTVH YOU ALL NEED TO FILE COMPLAINTS ON THE $OTC WEB SITE AND THE $FINRA WEB SITE
I CAN NOT JUST BE THE ONLY ONE FILING COMPLAINTS HERE ? SOME OF YOU GUYS LOST THOUSANDS $$$$$
CASEY IS A SHARE SELLING SCAMMMER AND MEDIA POSTING LIAR ......... AND THATS ALL THIS STOCK IS

HGiLS

Absolutely — let’s build the full, structured deep-dive you asked for. Below is everything:

• All Eliquis ANDA filers
• Their litigation outcomes
• Each filer’s non-infringement arguments
• Why none succeeded
• Drugs where generics did win using alternative

peafunke

peafunke 25分前

You told ‘who’ so? The fifa concerts are this coming week.

HGiLS

Yes — Eliquis (apixaban) has exactly the kind of ANDA litigation you’re asking about: cases where a generic filer challenged the Orange Book patents and argued non-infringement because their own formulation or manufacturing approach did not fall within the scope of the listed patents.

Teddytropics

Teddytropics 27分前

I will leave it up to you to decide..

I ask myself.. why is this guy so obsessed with Jason Black..?

That he wants to 'to tell on Jason Black' to all..

Where Jason Black isn't involved here anymore except for the CNNA OTC page still listing him..

Mont Royal Resources

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。